Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 22 Issue 9, September 2016

On p 1023 Lee et al. describe the effects of Withaferin A on mice with diet-induced obesity. They find that it can sensitise these mice to the effects of leptin resulting in bodyweight loss, reduced hepatic steatosis and improved glucose control. Cover depicts Withania somnifera, from which Withaferin A is derived. See also p 970. Credit: Charbonné Marc/EyeEm

News Feature

Top of page ⤴

News

Top of page ⤴

News Feature

Top of page ⤴

News & Views

  • A new study shows that withaferin A, a steroidal lactone isolated from Withania somnifera, can exert profound metabolic benefits in mice, including body-weight loss, reduced hepatic steatosis and improved glucose control.

    • Paul T Pfluger
    • Matthias H Tschöp
    News & Views
  • A recent study suggests that exposure to the mold Aspergillus induces the production of antibodies that neutralize interferon-γ (IFN-γ), which increases the risk of mycobacterial disease.

    • Luigi D Notarangelo
    • Steven M Holland
    News & Views
Top of page ⤴

Review Article

  • Patterns of splicing are frequently altered in cancer, and genes that encode splicing regulatory factors are often mutated. Thus, recent strategies have emerged to target splicing alterations in cancer, which are reviewed here.

    • Stanley Chun-Wei Lee
    • Omar Abdel-Wahab
    Review Article
Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Search

Quick links